<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33872379</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1424-3997</ISSN><JournalIssue CitedMedium="Internet"><Volume>151</Volume><PubDate><Year>2021</Year><Month>Mar</Month><Day>15</Day></PubDate></JournalIssue><Title>Swiss medical weekly</Title><ISOAbbreviation>Swiss Med Wkly</ISOAbbreviation></Journal><ArticleTitle>Early advance care planning in amyotrophic lateral sclerosis patients: results of a systematic intervention by a palliative care team in a multidisciplinary management programme - a 4-year cohort study.</ArticleTitle><Pagination><StartPage>w20484</StartPage><MedlinePgn>w20484</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4414/smw.2021.20484</ELocationID><ELocationID EIdType="pii" ValidYN="Y">Swiss Med Wkly. 2021;151:w20484</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Although recommended, the implementation of early advance care planning is suboptimal in amyotrophic lateral sclerosis (ALS) patients. Barriers to advance care planning include healthcare professionals&amp;rsquo; and patients&amp;rsquo; reluctance, and uncertainty about the right time to initiate a discussion.</AbstractText><AbstractText Label="AIM OF THE STUDY">To determine how often advance care planning was initiated, and the content of the discussion in a first routine palliative care consultation integrated within a multidisciplinary management programme.</AbstractText><AbstractText Label="METHODS">Between June 2012 and September 2016, a prospective cohort study was conducted in Geneva University Hospitals. Sixty-eight patients were seen every 3 months for a 1-day clinical evaluation in a day care centre.</AbstractText><AbstractText Label="RESULTS">The patients&amp;rsquo; mean &amp;plusmn; standard deviation age was 68.6 &amp;plusmn; 11.9 years, 50% were women. Four patients were excluded because of dementia. Advance care planning was initiated with 49 (77%) patients in the first palliative care consultation. Interventions most often addressed were cardiopulmonary resuscitation (49%), intubation and tracheostomy (47%) and palliative sedation (36.7%). Assisted suicide was discussed with 16 patients (36.6%). Functional disability was the only factor associated with initiation of advance care planning. Nearly half of the patients wrote advance directives (45%) or designated a healthcare surrogate (41%). Bulbar onset, functional disability and noninvasive ventilation were not associated with the completion of advance directives.</AbstractText><AbstractText Label="CONCLUSION">Early initiation of advance care planning is feasible in most ALS patients during a routine consultation, and relevant treatment issues can be discussed. All ALS patients should be offered the opportunity to write advance directives as completion was not associated with disease severity.&amp;nbsp.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sukockien&#x117;</LastName><ForeName>Egl&#x117;</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Clinical Neurosciences, Geneva University Hospitals, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iancu Ferfoglia</LastName><ForeName>Ruxandra</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Clinical Neurosciences, Geneva University Hospitals, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boegli</LastName><ForeName>Monique</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pain Consultation, Division of Clinical Pharmacology and Toxicology, Department of Acute Medicine, Geneva University Hospitals, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lefranc Barranco</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pain Consultation, Division of Clinical Pharmacology and Toxicology, Department of Acute Medicine, Geneva University Hospitals, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Truffert</LastName><ForeName>Andr&#xe9;</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Clinical Neurosciences, Geneva University Hospitals, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xe9;ritier Barras</LastName><ForeName>Anne-Chantal</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Clinical Neurosciences, Geneva University Hospitals, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Genton</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Nutrition, Department of Medical Specialties, Geneva University Hospitals, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leuchter</LastName><ForeName>Igor</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of ENT, Department of Clinical Neurosciences, Geneva University Hospitals, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adler</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Diseases, Department of Medicine, Geneva University Hospitals, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janssens</LastName><ForeName>Jean-Paul</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Diseases, Department of Medicine, Geneva University Hospitals, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Escher</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Palliative Care Consultation, Division of Palliative Medicine, Department of Rehabilitation and Geriatrics, Geneva University Hospitals, Switzerland / Unit for Development and Research in Medical Education (UDREM), Faculty of Medicine, University of Geneva, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Swiss Med Wkly</MedlineTA><NlmUniqueID>100970884</NlmUniqueID><ISSNLinking>0036-7672</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D032722" MajorTopicYN="Y">Advance Care Planning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010166" MajorTopicYN="N">Palliative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>19</Day><Hour>17</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33872379</ArticleId><ArticleId IdType="doi">10.4414/smw.2021.20484</ArticleId><ArticleId IdType="pii">Swiss Med Wkly. 2021;151:w20484</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>